IGF1 and adenoma: Other epidemiologic studies investigated IGF-1 and its primary binding protein IGFBP-3, which controls IGF-1 bioavailability, in relation to adenoma recurrence since IGF-1 promotes cell proliferation and inhibits apoptosis [90].